A peptide derived from bee venom-secreted phospholipase A2 inhibits replication of T-cell tropic HIV-1 strains via interaction with the CXCR4 chemokine receptor.

@article{Fenard2001APD,
  title={A peptide derived from bee venom-secreted phospholipase A2 inhibits replication of T-cell tropic HIV-1 strains via interaction with the CXCR4 chemokine receptor.},
  author={David Fenard and G{\'e}rard Lambeau and Thomas Maurin and Jean Claude Lefebvre and Alain Doglio},
  journal={Molecular pharmacology},
  year={2001},
  volume={60 2},
  pages={
          341-7
        }
}
We have previously shown that secreted phospholipases A2 (sPLA2) from bee and snake venoms have potent anti-human immunodeficiency virus (HIV) activity. These sPLA2s block HIV-1 entry into host cells through a mechanism linked to sPLA2 binding to cells. In this study, 12 synthetic peptides derived from bee venom sPLA2 (bvPLA2) have been tested for inhibition of HIV-1 infection. The p3bv peptide (amino acids 21 to 35 of bvPLA2) was found to inhibit the replication of T-lymphotropic (T-tropic… 

Figures from this paper

Identification of a D-amino acid decapeptide HIV-1 entry inhibitor.

Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2

It is shown that PLA2s from snake venoms protect Vero E6 cells against SARS-CoV-2 cytopathic effects and are promising for the development of antiviral drugs that target the viral envelope.

Anti-HIV Activity of Snake Venom Phospholipase A2s: Updates for New Enzymes and Different Virus Strains

The results indicate that snake PLA2s are capable of inhibiting syncytium formation between chronically HIV-infected cells and healthy CD4-positive cells and block HIV binding to cells, and might be considered as candidates for lead molecules in anti-HIV drug development.

Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2

It is shown that PLA 2 s from snake venoms protect Vero E6 cells against SARS-CoV-2 cytopathic effects and are promising for the development of antiviral drugs that target the viral envelope, and could also be useful tools to study the interaction of viruses with host cells.

HIV type 1 tropism and inhibitors of viral entry: clinical implications.

How an accurate quantification of HIV coreceptor usage is essential for the successful management of HIV-infected individuals in this new era of entry inhibitors, mainly CCR5- or CXCR4-antagonists is discussed.

Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases

Recent advances and the translation of new knowledge and discoveries into novel interventional strategies for clinical application are reviewed and discussed.

Hypothesis of snake and insect venoms against Human Immunodeficiency Virus: a review

Snake venom and human Phospholipase A2 (PLA2) have potential anti-viral activity through inhibition of virion entry into the cells, however, all these require further evaluation in order to establish its role against HIV as an independent one or as a supplement.
...

References

SHOWING 1-10 OF 41 REFERENCES

A Small Molecule CXCR4 Inhibitor that Blocks T Cell Line–tropic HIV-1 Infection

T22 is a small molecule CXCR4 inhibitor that blocks T cell line–tropic HIV-1 entry into target cells and inhibits Ca2+ mobilization induced by pre–B cell growth stimulating factor (PBSF)/SDF-1 stimulation through CX CR4.

Secreted phospholipases A2, a new class of HIV inhibitors that block virus entry into host cells

It is shown that several sPLA2s protect human primary blood leukocytes from the replication of various macrophage and T cell–tropic HIV-1 strains, and the antiviral activity appears to involve a specific interaction of s PLA2s to host cells.

A Small-molecule Inhibitor Directed against the Chemokine Receptor CXCR4 Prevents its Use as an HIV-1 Coreceptor

ALX40-4C represents a small-molecule inhibitor of HIV-1 infection that acts directly against a chemokine receptor at the level of Env-mediated membrane fusion.

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

The identification of a human chemokine of the CXC type, stromal cell-derived factor 1 (SDF-1), as the natural ligand for LESTR/fusin, and the term CXCR-4 is proposed for this receptor, in keeping with the new Chemokine-receptor nomenclature.

CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1

Recombinant CC CKR5, a G protein-coupled receptor for these chemokines, rendered CD4-expressing nonhuman cells fusion-competent preferentially with macrophage-tropic Envs, and is thus a fusion cofactor for HIV-1 strains.

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

Recombinant CC CKR5, a G protein-coupled receptor for these chemokines, rendered CD4-expressing nonhuman cells fusion-competent preferentially with macrophage-tropic Envs, and is thus a fusion cofactor for HIV-1 strains.

Epitope specificity of bee venom phospholipase A2-specific suppressor T cells which produce antigen-binding glycosylation inhibiting factor.

The results collectively indicate that the antigen-binding GIF and TCR on the cell source of the factor interact with a common epitope which is exposed on the surface of a nominal antigen.

Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4.

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

A cofactor for HIV-1 (human immunodeficiency virus-type 1) fusion and entry was identified with the use of a novel functional complementary DNA (cDNA) cloning strategy that is a putative G protein-coupled receptor with seven transmembrane segments.

Identification of a major co-receptor for primary isolates of HIV-1

The principal cofactor for entry mediated by the envelope glycoproteins of primary macrophage-tropic strains of HIV-1 is CC-CKR-5, a receptor for the β-chemokines RANTES, Mip-1α and MIP-1β.